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Abstract: This study evaluated the biocompatibility of degradable
polydioxanone (PDS) electrospun drug delivery systems (hereaf-
ter referred as matrices) containing metronidazole (MET) or cipro-
floxacin (CIP) after subcutaneous implantation in rats. Sixty adult
male rats were randomized into six groups: SHAM (sham sur-
gery); PDS (antibiotic-free matrix); 1MET (one 25 wt% MET
matrix); 1CIP (one 25 wt% CIP matrix); 2MET (two 25 wt% MET
matrices); and 2CIP (two 25 wt% CIP matrices). At 3 and 30 days,
animals were assessed for inflammatory cell response (ICR),
collagen fibers degradation, and oxidative profile (reactive oxygen
species [ROS]; lipid peroxidation [LP]; and protein carbonyl
[PC]). At 3 days, percentages of no/discrete ICR were 100, 93.3,
86.7, 76.7, 50, and 66.6 for SHAM, PDS, 1MET, 1CIP, 2MET,
and 2CIP, respectively. At 30 days, percentages of no/discrete
ICR were 100% for SHAM, PDS, 1MET, and 1CIP and 93.3% for
2MET and 2CIP. Between 3 and 30 days, SHAM, 1CIP, and 2CIP
produced collagen, while 1MET and 2MET were unchanged.
At 30 days, the collagen fiber means percentages for SHAM,
PDS, 1MET, 1CIP, 2MET, and 2CIP were 63.7, 60.7, 56.6, 62.6,
51.8, and 61.7, respectively. Antibiotic-eluting matrices showed
similar or better oxidative behavior when compared to PDS,
except for CIP-eluting matrices, which showed higher levels
of PC compared to SHAM or PDS at 30 days. Collectively,
our findings indicate that antibiotic-eluting matrices may be
an attractive biocompatible drug delivery system to fight per-
iodontopathogens. © 2019 Wiley Periodicals, Inc. J Biomed Mater Res
Part B: Appl Biomater 108B:306–315, 2020.
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INTRODUCTION
Periodontitis is an inflammatory disorder that leads to the
destruction of the teeth supporting tissues, ultimately resulting
in tooth loss. According to data from the World Health Orga-
nization (WHO), 10.8% of the adult populations worldwide
have severe periodontitis.1 Moreover, severe periodontitis is
the sixth most prevalent condition in the world.2 Over the
last three decades, several regenerative-based strategies
aimed at periodontal tissue reconstruction have been
proposed3–6 and yet the ideal biomaterial and/or scaffold
is still to be found.7
Barrier membranes have been employed in the so-called
guided tissue/bone regeneration (GTR/GBR) approaches.8,9
Nevertheless, current membranes do not possess the struc-
tural integrity required to resist compressive forces to main-
tain the space necessary for periodontal regeneration.10,11
Conventional, nonresorbable membranes have the disadvantage
of necessitating a second surgery, with the associated additional
discomfort and economic burden. Polyester-based membranes
(e.g., polydioxanone [PDS]) are biodegradable, allow for tissue
integration, and are easier to handle when compared to
non-resorbable counterparts. In terms of periodontal defect
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disinfection prior to tissue regeneration, biodegradable
nanofibrous antibiotic-eluting delivery systems have the
potential to endow a bacteria-free microenvironment,
reducing risk of GTR/GBR failure due to infection,12 while
minimizing adverse effects associated with the use of sys-
temic antibiotics.13
Numerous authors have explored the electrospinning
technique to generate nanofibrous matrices for drug
delivery.10,14–18 Bottino and colleagues19,20 presented
mechanically strong biodegradable PDS-based antibiotic-eluting
matrices, which demonstrated: (1) adequate mechanical proper-
ties to sustain handling and maintain the overall structure
during regenerative procedures; (2) an inhibitory effect on
the biofilm of Porphyromonas gingivalis, Aggregatibacter
actinomycetemcomitans, and Fusobacterium nucleatum with
no detrimental effects on commensal bacteria biofilm
(e.g., Lactobacillus casei); and (3) controlled release of an
adequate drug dose more than 7 days. Moreover, 25 wt %
MET matrices and its CIP counterparts released only 12%
and 40%, respectively, of the antibiotic during this period,
demonstrating the ability to sustain a controlled release for
a longer time period. Taken together, the ability to inhibit
periodontal pathogens enhances the clinical potential of the
proposed nanofibrous antibiotic-eluting matrices as a drug
delivery system for applications in periodontics. Thus, the
purpose of this investigation was to determine the inflam-
matory response of biodegradable PDS-based electrospun
antibiotic-eluting matrices containing metronidazole (MET)
or ciprofloxacin (CIP) using a rat subcutaneous implanta-
tion model. Initial (3 days) and late (30 days) inflammatory
responses were assessed based on degree of local inflam-
matory cell response (ICR), tissue oxidative status, and col-
lagen degradation.
MATERIAL AND METHODS
Synthesis of electrospun drug delivery systems
Polydioxanone monofilament surgical sutures (PDS II®, Ethicon,
Somerville, NJ) were cut into pieces and placed into glass vials
containing dichloromethane (Sigma-Aldrich, St. Louis, MO) to
remove the violet dye.19 Next, undyed PDS was then dissolved
in 1,1,1,3,3,3-hexafluoro-2-propanol (Sigma-Aldrich) at a 10 wt
% concentration. MET (Sigma-Aldrich) with a molecular weight
(Mw) of 171.15 g/mol or CIP (Sigma-Aldrich) with Mw of
331.346 g/mol was directly added at 25 wt % concentration
(respective to the total polymer weight) and mixed together
under vigorous stirring.19,20
Pure (i.e., antibiotic-free) PDS or antibiotic-containing
PDS solutions were individually loaded into plastic syringes
fitted with a 27-gauge stainless steel needle and electrospun
under optimized parameters (2 mL/h, 18-cm distance, and
15 kV). The fibers were collected at room temperature
(RT) on an aluminum-foil covered rotating mandrel. The
electrospun matrices were dried in vacuum desiccators at
RT for at least 48 h to remove any residual solvent.19
Experimental design
The experimental protocol (#4141250315) followed the Ani-
mal Research: Reporting of In Vivo Experiments (ARRIVE)
guidelines and was approved by the Committee on Animal
Research of the Institution (Federal University of Santa Maria,
Santa Maria, RS, Brazil).
Sixty adult male rats (Rattus norvegicus, albinus, Wistar)
90 days old (250–300 g) were housed at a controlled tempera-
ture (23  1C), relative humidity (60%) with noise control
(maximum 85 decibels), and a standard light–dark cycle (12 h).
The animals were fed with regular rat pellets and distilled
water ad libitum and were acclimatized to the laboratory envi-
ronment for a period of 2 weeks before the experimental
procedures.
The animals were allocated into two groups (30 per group)
to evaluate the initial (3 days) and late (30 days) inflammatory
response to matrix subcutaneous implantation. The computer
software (Random Allocation Software, version 1.0, May 2004)
was used to randomly allocate the animals into the experimen-
tal groups (Table I). One study team member (RM) performed
the randomization process. The surgical procedures were
performed by one operator (PCP) in randomized sequence
order. The operator made subcutaneous pockets and was then
informed whether or not the animals received the nanofibrous
matrix. All matrices presented the same coloration and thus
avoided any potential bias.
The animals were anesthetized with intramuscular keta-
mine (70 mg/kg) and xylazine (6 mg/kg). The back of each
rat was shaved and scrubbed with chlorhexidine (2%) and
each rat was draped for sterile surgery. One incision (3 cm)
was performed through the skin on the right side of the mid-
line. For animals in the 2MET and 2CIP groups, one incision
(3 cm) on each side of the midline with at least a 2-cm sepa-
rating distance was made. For each incision, a pouch was
created subcutaneously (3–4 cm2) using blunt dissection.
One matrix (2 × 2 cm2) was implanted into each subcutane-
ous pouch, except for the SHAM animals. The skin incisions
TABLE I. Experimental Groups Description
Experimental groups
Number of animals to evaluate
initial inflammatory response: 3 days
Numbers of animals to evaluate
late inflammatory response: 30 days
SHAM One subcutaneous pocket (no matrix) 5 5
1PDS One PDS matrix 5 5
1MET One 25 wt % MET PDS matrix per rat 5 5
1CIP One 25 wt % CIP PDS matrix per rat 5 5
2MET Two 25 wt % MET PDS matrices per rat 5 5
2CIP Two 25 wt % CIP PDS matrices per rat 5 5
PDS: polydioxanone, CIP: ciprofloxacin, MET: metronidazole.
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were subsequently stitched with non-resorbable 6.0 sutures
(Ethicon) and adhesive strips (Leukostrip, Smith & Nephew
Ltda., São Paulo, SP, Brazil).
At 3 and 30 days, the animals were anesthetized with an
inhalation of isoflurane (3%) (Isoflurano, Instituto BioChimico
Indústria Farmacêutica Limitada, Itatiaia, RJ, Brazil) in an oxy-
gen carrier. Blood was collected by cardiocentesis (22G needle
and a 5-mL syringe) in EDTA anticoagulant tubes. Euthanasia
was performed by total exsanguination and the matrices were
explanted together with the surrounding peri-implantation
tissue to analysis. The specimens were sectioned in two equal
segments. One segment was used to analyze the tissue oxida-
tive status and the other segment was fixed in 4% buffered
formalin (72 h) prior to histological analysis (Figure 1).
Histological analysis
The segment used to provide histological analysis was cut into
two identical pieces.21 These tissue segments contained the
peripheral and the center region (Figure 1) of the implantation
bed. Further processing involved dehydration of the biopsies
and paraffin embedding. Accordingly, from each animal, two
consecutive 5-μm serial sections were cut from each segment
(the peripheral region and the center of the biopsies). Hema-
toxylin and eosin (H&E) staining was used for the first section,
and Masson’s trichrome (MT) (Sigma-Aldrich) and Picrosirius
Red (PRed, Picrosirius Red Staining, Easy Path®, São Paulo, SP,
Brazil) for the second and third sections, respectively.
The H&E sections were used to evaluate for the presence
and degree of inflammatory cell response (ICR) to the matrices.
Three fields of view (100×) from the peripheral and the central
sections were observed and scored from verbal description
using a 4-point scale22 considering polymorphonuclear
leukocytes/mononuclear cells: 0 = absent (no inflammatory
cells); 1 = mild or discrete (few inflammatory cells); 2 = moderate
(several inflammatory cells and increased reaction zone); and
3 = intense or severe (increased reaction zone, occasional foci of
neutrophil granulocytes and/or lymphocytes).23 This evaluation
was performed by one calibrated examiner (JM) via double mea-
surements of 10 specimens using a 1-week interval. The Kappa
valuewas 0.95.
The MT stained sections were digitized at 200× magni-
fication using optical microscopy (Axiovision; Carl Zeiss
MicroImaging, Jena, Germany). From the left margin of the
tissue sample, fields of view were numbered consecutively
toward the right margin. On average, 14 fields were dis-
played. Of these, fields 7, 8, and 9 were selected to deter-
mine the percentage of area occupied by collagen fibers
from the peripheral and central region, totaling six fields
of evaluation per rat. The image of the fields was obtained
using the image-processing software (Zen lite 2012 blue
edition, Carl Zeiss MicroImaging). The images were trans-
ferred to the ImageJ software (v1.50i, National Institutes
of Health, Bethesda, MD), binarized and the percentage of
area filled by collagen fibers was calculated.24 Descrip-
tive analysis of collagen fiber type was performed in the
same fields (7, 8, and 9) by polarized microscopy (Leica,
model DM2000, Wetzlar, Germany) at 400× using sec-
tions dyed with PRed. Figure 2 shows the position of the
analysis fields where the percentage of collagen fibers
was performed.
All histometric analyses were performed by examiners
(PCP and JM) who were blinded to the experimental groups.
FIGURE 1. Schematic diagram of oxidative and histological analysis protocol.
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ROS generation with DCH
The ROS levels were quantified using the oxidant-sensing fluo-
rescent probe, 2,7-dichlorofluorescein diacetate (DCHF-DA).25
Oxidation (DCHF-DA) to fluorescent dichlorofluorescein (DCF)
ratio was determined at 488 nm for excitation and 525 nm for
emission. Tissue samples were added to a medium containing
Tris–HCl buffer (0.01 mM, pH 7.4) and DCHF-DA was added to
the solution for 1 h until fluorescence measurements were
obtained. DCF-RS levels were corrected by protein content26
and expressed as a percentage of values from control.
Oxidative cellular damage by protein carbonyl
determination
Protein carbonyl (PC) determination is a type of protein oxida-
tion that can be promoted by ROS, referring to a process that
forms reactive ketones or aldehydes that can be reacted by
2,4-dinitrophenylhydrazine (DNPH) to form hydrazones. PC
level was measured according to a previously established pro-
tocol27 with minor modifications. In brief, aliquots of tissue
samples homogenized in Tris–HCl buffer (10 mM, pH 7.4) were
mixed with 0.2 mL of DNPH (10 mM). After 1 h of incubation
at RT in the dark, 0.5 mL of denaturing buffer (150 mM
sodium phosphate buffer, pH 6.8, 3% SDS), 2 mL of heptane
(99.5%), and 2 mL of ethanol (99.8%) were added sequen-
tially, mixed for 40 s and centrifuged for 15 min. Thereaf-
ter, the protein isolated from the interface was washed
twice with ethyl acetate/ethanol 1:1 (v/v) and suspended
in denaturing buffer. Each sample was measured at 370 nm
against the corresponding HCl sample (blank), and total
carbonylation was calculated using a molar extinction coef-
ficient of 22,000 M−1 cm−1.28 The results were expressed
as nmol carbonyl/g tissue−1.
Oxidative cellular damage by lipidic peroxidation
estimation
Lipidic peroxidation (LP), or the reaction of oxygen with unsat-
urated lipids, occurs when reactive oxygen species (ROS) attack
polyunsaturated fatty acids of the fatty acid membrane,
initiating a self-propagating chain reaction. The destruc-
tion of membrane lipids and the end products of such LP
reactions are hazardous to cell viability. One product of LP
is malondialdehyde (MDA), which presents a facile reaction
with thiobarbituric acid (TBA), yielding an intensely colored
fluorescent chromogen. LP was measured by the reaction of
MDA with TBA.29 A pink chromogen was generated and
spectrophotometrically measured at 532 nm. The TBARS
levels (substances that react with TBA) were expressed as
nmol of MDA g tissue.
Statistical analysis
The rat was the unit analysis. The degree of ICR data was
shown as median, minimum, and maximum values. The dis-
tribution frequency of each score of degree of ICR was calcu-
lated per rat (considering six evaluation fields). Then, the
mean percentage of absent/mild (score of 0 and 1) and mod-
erate/severe (score of 2 and 3) was calculated. The data of
collagen fibers’ percentage, ROS, PC, and LP levels were
presented as mean and standard deviation. Normality of the
FIGURE 2. Localization of the collagen fibers percentage analysis using Masson’s trichrome (MT) and Picrosirius Red (PRed) dye. (A) Epidermis.
(B) Dermis. (C) Subcutaneous tissue. (D) Muscle tissue.
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data was analyzed using the Shapiro–Wilk test. The intergroup
analyses were performed using two-way ANOVA and post hoc
Duncan’ test. Differences were considered significant when
p < 0.05. The program Statistics 8.0 was used for all analyses.
RESULTS
No animal was lost during the experimental period, and no
adverse effects were observed.
Degree of ICR
The median (minimum and maximum) of the inflammation
scores are presented in Table II. At 3 days, the implantation
of 2 MET matrices revealed higher median values. This find-
ing agrees with the analyses of the mean percentage of fields
presenting no or discrete inflammatory infiltration (score of
0 and 1), for which 2MET showed the lowest percentage
50%, thus being the only group that presented statistical dif-
ference from SHAM (p = 0.041). In the other groups, the mean
percentage of fields presenting no or discrete inflammatory
infiltration were of 100, 93.3, 86.7, 73.2, and 66.6% for SHAM,
PDS, 1MET, 1CIP, and 2CIP, respectively [Figure 3(A)], with no
statistical difference between groups. At 30 days, 1MET, 2MET,
and 2CIP groups still had some area with moderate inflamma-
tion (Table II). No statistically difference was observed between
groups. Nearly all the groups presented 100% of no/discrete
cellular infiltration, except 1MET, 2MET, and 2CIP, which
showed 96.6, 90, and 90% of fields in this condition, respec-
tively [Figure 3(B)]. At both evaluation times (3 and 30 days), no
rat showed any field with severe inflammation. Figures 4 and 5
show representative H&E micrographs after 3 days at different
magnifications.
Collagen fibers
Table III shows the mean percentage of collagen fibers in
the groups at 3 and 30 days. At 3 days, the PDS matrices
seemed to stimulate collagen production. 2MET, 2CIP, and
1CIP showed lower statistically percentage of collagen
fibers than PDS. All groups were statistically similar to the
SHAM. The reduction percentage of collagen fibers when
compared to SHAM was 14.5, 9.1, and 7.7% for 1CIP, 2CIP,
and 2MET, respectively. Interestingly, between 3 and 30 days,
the SHAM, 1CIP, and 2CIP groups produced collagen, whereas
the 1MET and 2MET maintained the same percentage of colla-
gen fibers seen at 3 days. The 2MET group demonstrated a
reduction of approximately 18%, in the collagen fiber percent-
age at 30 days when compared to the SHAM. The other
groups (PDS, 1MET, 1CIP, and 2CIP) were statistically similar
to the SHAM. Most of the fibers were type I, dense, and thick.
Few type III fibers, interlaced with type I fibers, were noted.
Oxidative status profile
The oxidative status data are shown in Figure 6. At 3 days,
the PDS matrices significantly increased the ROS levels
(p < 0.01) and cellular damage from LP (p < 0.01) and PC
(p = 0.012) when compared to the SHAM. At 30 days, PDS
and SHAM showed similar oxidative profile. At 3 days, the
cellular damage from LP was in ascending order: SHAM =
2MET < 1MET = 2CIP < 1CIP < PDS (p < 0.05). At 30 days, the
antibiotic-eluting matrices presented lower LP levels when
compared to the PDS or SHAM (p < 0.05). Concerning PC levels
TABLE II. Median Inflammation Scores (Minimum and Maximum) at 3 and 30 Days
SHAM PDS 1MET 2MET 1CIP 2CIP
3 days 1 (0-1) 1 (1-2) 1 (0-2) 1.5 (0-2) 1 (1-2) 1 (1-2)
30 days 0 (0-1) 0 (0-1) 0 (0-2) 1 (0-2) 1 (0-1) 1 (0-2)
Score system from verbal description using a 4-point scale considering polymorphonuclear leukocytes/mononuclear cells: 0 = absent (no inflam-
matory cells); 1 = mild or discrete (few inflammatory cells); 2 = moderate (several inflammatory cells and increased reaction zone); and 3 = intense
or severe (increased reaction zone, occasional foci of neutrophil granulocytes and/or lymphocytes). Sections were viewed at 100× and graded by a
blinded and calibrated examiner. Five animals per group and time point were used.
FIGURE 3. Mean percentage of absent/mild (score of 0 and 1) and mod-
erate/severe (score of 2 and 3) ICR in the experimental groups at (A) 3 days
and (B) 30 days. Five animals per group and time point were used.
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at 3 days, CIP-eluting matrices showed similar behavior to the
SHAM. The 2CIP was the only that presented PC levels lower
statistically than PDS (p = 0.02). At 30 days, all groups were
statistically similar to the SHAM, with exception of 1CIP
(p = 0.025). In general, antibiotic-eluting matrices displayed a
protective effect in terms of oxidative cellular damage with
regard to LP analyses but not in terms of PC when compared
to antibiotic-free PDS matrices.
FIGURE 4. Representative images of H&E stained slides at 3 days (lower magnification = 100×). General view of the histological section (MF: muscle
fiber, CT: connective tissue, SF: matrix). All slides are oriented with skeletal muscle at the upper aspect. Black arrow indicates a blood vessel.
(A) SHAM, (B) PDS, (C) 1MET, (D) 2MET, (E) 1CIP, and (F) 2CIP.
FIGURE 5. Representative images of H&E stained slides at 3 days (Higher magnifications = 200× left and 400× right). (A) Sham and PDS. (B) 1MET,
1CIP, 2MET, and 2CIP. The degree of ICR was classified according to a score system from verbal description using a 4-point scale considering poly-
morphonuclear leukocytes/mononuclear cells: 0 = absent (no inflammatory cells); 1 = mild or discrete (few inflammatory cells); 2 = moderate
(several inflammatory cells and increased reaction zone); and 3 = intense or severe (increased reaction zone, occasional foci of neutrophil
granulocytes and/or lymphocytes). None of the groups showed severe inflammatory infiltrate. Red arrow (×): blood vessel; white arrow (×): inflam-
matory cells; asterisk (*): fibroblast.
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DISCUSSION
The aim of this study was to investigate the biocompatibility of
PDS-based antibiotic-eluting matrices in a rat subcutaneous
implantation model. Tissue response was evaluated based on
the degree of inflammatory cellular response, percentage
collagen fibers by histological analysis, and oxidative profile
by biochemical analysis. Alterations during early inflamma-
tory response (3 days) associated with the matrices without
antibiotics were observed when compared to the SHAM. How-
ever, at 30 days, these alterations were nullified. Regarding
FIGURE 5. Continued
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the antibiotic-eluting matrices, the alterations were more
prominent at 3 days for all outcomes. At 30 days, 1MET, 2MET,
and 2CIP did not reach the same inflammatory parameters as
observed in PDS or SHAM groups, which showed 100% of
no/discrete ICR. Moreover, MET-eluting matrices impaired
collagen fibers formation between 3 and 30 days.
A higher degree of inflammatory cellular response was
observed when two incisions were performed (on each side of
the midline) and two antibiotic-eluting matrices were implanted
per animal. In the 2MET and 2CIP animals, one antibiotic matrix
was implanted on each side of the midline, but the histological
analysis was carried out from only one tissue side. Then, it is pos-
sible that the drug released frommatrix localized on the left side
reached the opposite side by tissue diffusion and/or bioavailabil-
ity. It is worthmentioning that tissue diffusion and bioavailability
of a drug depend on pH, local vascularization, presence of a bac-
terial enzyme, and drug physical and chemical properties, such
as size and molecular weight, charge, dissociation constants,
liposolubility, and partition coefficient.30,31 Drugs administered
subcutaneously can reach systemic circulation either by uptake
via blood capillaries or indirectly by lymphatic vessels32 and also
can exhibit diffusion and advection into extracellular matrix
before uptake by the lymphatic capillaries draining the site.31
Another plausible explanation for these differences is the fact
that, regardless of the antibiotic-eluting matrix implantation, two
incisions were performed, promoting higher tissue injury, and
thus a greater ICR at both implantation sites.
Oxygen reactive species (ROS) are produced in the mito-
chondria during respiratory chain electron transport, where
they are rapidly transformed into more inactive species by the
antioxidant defenses. However, increased production of ROS
during the inflammatory process cannot be counteracted by a
concomitant increase in antioxidant defenses, thus leading to
cellular damage that can be measured as protein carbonylation
and lipidic peroxidation. At the sites of inflammation, there is a
considerable overproduction of various oxygen reactive species
by activated neutrophils and macrophages. At 3 days, 2 MET
was the only group that simultaneously produced higher
cellular damage from oxidative mechanisms (PC and LP) when
compared to the SHAM. In general, antibiotic-eluting matrices
demonstrated similar or lower oxidative damage when com-
pared to the antibiotic-free PDS-based counterparts. At 30 days,
antibiotic-eluting matrices presented similar behavior to the
PDS or SHAM groups.
With respect to collagen fibers, only MET-eluting matrices
were associated with impaired collagen fibers’ formation during
the experimental period, because the collagen lost during the
initial inflammatory response was not regenerated. However,
one should interpret these findings with caution, since 1MET
showed an 11% reduction relative to SHAM; and a 6.7% reduc-
tion relative to PDS at 30 days. Since PDS is an FDA-approved
bioresorbable synthetic polymer, such impairment (6.7%)
should not be considered clinically significant. Therefore,
although quantitative data obtained from preclinical studies
TABLE III. Mean Percentage of Collagen Fibers (standard deviation) at 3 and 30 Days
SHAM PDS 1MET 2MET 1CIP 2CIP
3 days 56.8 (5.0) 66.9 (4.8) 58.7 (7.4) 52.4 (7.0)a 48.6 (3.4)a 51.6 (2.6)a
30 days 63.7 (7.0) 60.7 (4.9) 56.6 (4.2) 51.8 (3.0)b 62.6 (3.4) 61.7 (3.6)
One-way ANOVA and Tukey’s post hoc test (p < 0.05). Five animals per group and time point were used.
At 3 days: No statistical difference was observed among antibiotics groups. All groups were statistically similar to the SHAM. Groups with two
antibiotics matrices (2MET, 2CIP) and the 1CIP group presented statistically lower percentage of collagen fibers than PDS (a).
At 30 days: No statistical difference was observed among antibiotics groups. Only 2MET group presented statistically lower collagen fiber per-
centage when compared to the SHAM (b). None of the groups showed difference when compared to the PDS.
aRepresents statistically significant difference compared to PDS at 3 days.
bRepresents statistically significant difference compared to SHAM at 30 days.
FIGURE 6. Mean and standard deviation of the LP (A), PC (B), ROS (C) levels in the experimental groups. Different lower-case letters represent statis-
tical differences between groups at 3 days (p < 0.05). Different upper-case letters represent statistical differences at 30 days (p < 0.05). Two-way
ANOVA and Duncan’s test. For example, at 3 days, PDS showed statistically higher LP levels when compared to all other groups; at 30 days, no dif-
ference was observed between PDS and SHAM, but LP levels were statistically higher than 2MET, 1CIP and 2CIP.
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cannot be applied directly to humans, one could anticipate
a fairly similar behavior.
Although it was not the focus of the present study, our
data show a discrete presence of multinucleated giant cells,
which are characteristic of foreign body reaction, at 3 and
30 days for PDS, 1MET, 2MET, 1CIP, and 2CIP (data not
shown). No difference was verified among the groups. The
discrete presence of this cellular type at 30 days might indi-
cate that the biomaterial was not yet completely degraded.
In the present study, antibiotic-eluting PDS-based matrices
were evaluated using a subcutaneous implantation model in
the rat. The proposed matrices have been designed to be used
to treat periodontal infection and/or to perform a barrier
function as required in GTR/GBR regenerative approaches. It
is worth mentioning that the overall tissue response upon
matrices’ implantation was investigated in the absence of a
microbial challenge. Thus, it is possible that in the presence of
bacterial infection, the antibiotic-eluting nanofibrous matrices
could work reducing the inflammatory alterations when com-
pared to the antibiotic-free PDS matrices; therefore, this issue
should be considered in future studies.
CONCLUSIONS
Collectively, the findings of this study demonstrate that
antibiotic-eluting biodegradable polymeric matrices did not
result in significant damage to tissue healing beyond that
obtained from surgical handling (SHAM) or the use of
antibiotic-free (PDS only) matrices. Considering the previously
established antimicrobial properties of the polymer-based
matrices evaluated herein, the results from this biocompatibil-
ity study suggest that our antibiotic-eluting matrices may
offer an attractive drug delivery system for treating periodon-
tal infection. Further in vivo studies assessing not only bacte-
rial reduction but also the overall tissue response within a
more clinically relevant scenario (i.e., presence of infection)
are warranted to confirm the clinical potential of the pro-
posed antibiotic-eluting drug delivery systems.
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